Targeting PI3K in cancer: mechanisms and advances in clinical trials

Overview of attention for article published in Molecular Cancer, February 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets
blogs: 2 blogs
twitter: 1 X user

patent: 2 patents
f1000: 1 research highlight platform

Citations

dimensions_citation: 1011 Dimensions

Readers on

mendeley: 1015 Mendeley

Summary News Blogs X Patents Research highlights Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

METHODS OF CANCER TREATMENT USING ANTI-OX40 ANTIBODIES IN COMBINATION WITH PI3 KINASE…

Application EP-4061851-A4

European Patent Office

DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY

Application WO-2021113651-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.